mbiomics GmbH
PrivateLast Round
Series A
May 4, 2026
Total Funding Raised
$35.01M
Momentum Score
50 /100
Company Overview
mbiomics GmbH is a biotechnology company that develops live bacterial therapeutics using its proprietary microbiome diagnostic platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mbiomics GmbH Comps
Public and private peers based on sector, stage, and business model.
mbiomics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2026 | ||||
| Series A | Mar 23, 2023 |
Key People
Founding team and executive leadership
mbiomics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Bayern Kapital | Series A |
| High-Tech Gründerfonds | Series A |
| MIG Fonds | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$35M round led by Bayern Kapital and MIG Fonds.
- Apr 29, 2026
Lead candidate MBX-116 preparing for clinical evaluation for advanced melanoma.
mbiomics GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mbiomics GmbH's valuation, stock price, and market status.
